516 related articles for article (PubMed ID: 31100603)
21. Neurobiology of Kratom and its main alkaloid mitragynine.
Suhaimi FW; Yusoff NH; Hassan R; Mansor SM; Navaratnam V; Müller CP; Hassan Z
Brain Res Bull; 2016 Sep; 126(Pt 1):29-40. PubMed ID: 27018165
[TBL] [Abstract][Full Text] [Related]
22. The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.).
Chittrakarn S; Keawpradub N; Sawangjaroen K; Kansenalak S; Janchawee B
J Ethnopharmacol; 2010 Jun; 129(3):344-9. PubMed ID: 20371282
[TBL] [Abstract][Full Text] [Related]
23. Kratom-Associated Fatalities in Northern Nevada-What Mitragynine Level Is Fatal?
Schmitt J; Bingham K; Knight LD
Am J Forensic Med Pathol; 2021 Dec; 42(4):341-349. PubMed ID: 34091497
[TBL] [Abstract][Full Text] [Related]
24. Kratom policy: The challenge of balancing therapeutic potential with public safety.
Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
[TBL] [Abstract][Full Text] [Related]
25. Accelerated Solvent Extractions (ASE) of
Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
[No Abstract] [Full Text] [Related]
26. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
27. Detection of Mitragynine in Mitragyna Speciosa (Kratom) Using Surface-Enhanced Raman Spectroscopy with Handheld Devices.
Lanzarotta A; Thatcher MD; Lorenz LM; Batson JS
J Forensic Sci; 2020 Sep; 65(5):1443-1449. PubMed ID: 32453477
[TBL] [Abstract][Full Text] [Related]
28. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method.
Berthold EC; Kamble SH; Raju KS; King TI; Popa R; Sharma A; León F; Avery BA; McMahon LR; McCurdy CR
J Pharm Biomed Anal; 2021 Feb; 194():113778. PubMed ID: 33277117
[TBL] [Abstract][Full Text] [Related]
29. Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine.
Maxwell EA; King TI; Kamble SH; Raju KSR; Berthold EC; León F; Hampson A; McMahon LR; McCurdy CR; Sharma A
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):459-463. PubMed ID: 33847897
[TBL] [Abstract][Full Text] [Related]
30. Respiratory effects of oral mitragynine and oxycodone in a rodent model.
Henningfield JE; Rodricks JV; Magnuson AM; Huestis MA
Psychopharmacology (Berl); 2022 Dec; 239(12):3793-3804. PubMed ID: 36308562
[TBL] [Abstract][Full Text] [Related]
31. Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Mass Spectrom; 2010 Nov; 45(11):1344-57. PubMed ID: 20967737
[TBL] [Abstract][Full Text] [Related]
32. Determination of Mitragynine in
Mudge EM; Brown PN
J AOAC Int; 2017 Jan; 100(1):18-24. PubMed ID: 27725074
[TBL] [Abstract][Full Text] [Related]
33. Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.).
Limsuwanchote S; Wungsintaweekul J; Keawpradub N; Putalun W; Morimoto S; Tanaka H
Forensic Sci Int; 2014 Nov; 244():70-7. PubMed ID: 25216455
[TBL] [Abstract][Full Text] [Related]
34. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
[TBL] [Abstract][Full Text] [Related]
35. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.
Singh D; Narayanan S; Vicknasingam B; Corazza O; Santacroce R; Roman-Urrestarazu A
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28544011
[TBL] [Abstract][Full Text] [Related]
36. "Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products".
Fuenffinger N; Ritchie M; Ruth A; Gryniewicz-Ruzicka C
J Pharm Biomed Anal; 2017 Feb; 134():282-286. PubMed ID: 27951469
[TBL] [Abstract][Full Text] [Related]
37. Kratom (Mitragyna speciosa): worldwide issues.
Ramanathan S; McCurdy CR
Curr Opin Psychiatry; 2020 Jul; 33(4):312-318. PubMed ID: 32452943
[TBL] [Abstract][Full Text] [Related]
38. CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S; Kerrigan S
J Anal Toxicol; 2020 May; 44(4):301-313. PubMed ID: 32008041
[TBL] [Abstract][Full Text] [Related]
39. Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom.
Le D; Goggin MM; Janis GC
J Anal Toxicol; 2012; 36(9):616-25. PubMed ID: 23024321
[TBL] [Abstract][Full Text] [Related]
40. Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia.
Singh D; Müller CP; Vicknasingam BK; Mansor SM
J Psychoactive Drugs; 2015; 47(2):125-31. PubMed ID: 25950592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
